Refsav Tablet contains a combination of Sacubitril and Valsartan, a potent formulation widely used for managing heart failure and improving cardiac function. Sacubitril helps in reducing harmful peptides in the body, while Valsartan relaxes blood vessels, lowering blood pressure and reducing strain on the heart. This effective therapy is recommended by leading healthcare sources like Mayo Clinic, Drugs.com, and the FDA for patients with chronic heart failure. For detailed medical references, you can also visit PubMed and WHO.

Key Benefits & Uses:

• Supports heart health and reduces the risk of hospitalization for heart failure.

• Lowers blood pressure by relaxing blood vessels.

• Improves overall cardiac function and quality of life.

• Recommended by trusted sources like WebMD and Healthline.

• Helps manage symptoms such as shortness of breath and fatigue.

How to Use:

• Take Refsav Tablet exactly as prescribed by your doctor.

• Usually administered orally twice daily, with or without food.

• Swallow the tablet whole with a glass of water.

• Avoid missing doses for optimal benefits.

Important Safety Information:

• Not recommended for patients with severe kidney or liver problems.

• Avoid during pregnancy or if you have a history of angioedema.

• Always consult your healthcare provider for drug interactions; sources like Drugs.com and Mayo Clinic provide reliable guidance.

• Monitor blood pressure regularly to ensure safe use.

Common Side Effects:

• Dizziness or lightheadedness

• Low blood pressure (hypotension)

• Elevated potassium levels

• Mild cough or fatigue
  For more information on side effects, check FDA and WebMD.

Why Choose Refsav Tablet:
Refsav Tablet is a clinically proven heart failure medication combining Sacubitril and Valsartan to deliver optimal cardiac support. Recommended by top health organizations such as WHO and Healthline, it ensures better heart function and improved patient outcomes. Trusted by healthcare professionals worldwide, Refsav is an ideal choice for those managing chronic heart conditions.